Search

Author/Creator Kubal, Timothy E.

1. Bone marrow cellularity at day 14 is the most important predictive factor for response in patients with AML who require double‐induction chemotherapy: Analysis from a large, single institution experience. Issue 3 (3rd February 2017)

Authors:
Griffin, Patrick T.; Komrokji, Rami S.; Sweet, Kendra; Al Ali, Najla H.; Padron, Eric; Kubal, Timothy E.; List, Alan F.; Lancet, Jeffrey E.
Journal:
American journal of hematology
Issue:
Volume 92:Issue 3(2017:Mar.)
Page Start:
232
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Prospective CYP2C19‐Guided Voriconazole Prophylaxis in Patients With Neutropenic Acute Myeloid Leukemia Reduces the Incidence of Subtherapeutic Antifungal Plasma Concentrations. Issue 3 (1st November 2019)

Authors:
Hicks, J. Kevin; Quilitz, Rod E.; Komrokji, Rami S.; Kubal, Timothy E.; Lancet, Jeffrey E.; Pasikhova, Yanina; Qin, Dahui; So, Wonhee; Caceres, Gisela; Kelly, Kerry; Salchert, Yasmina S.; Shahbazian, Kevin; Abbas‐Aghababazadeh, Farnoosh; Fridley, Brooke L.; Velez, Ana P.; McLeod, Howard L.; Green...
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 107:Issue 3(2020)
Page Start:
563
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗